ArticleJournal of nanobiotechnology2026
LLMs uncover 6M1@C60's therapeutic targets: inhibiting atherosclerotic progression via NRF2/HO-1/GPX4 axis-mediated ferroptosis suppression.
Wenhao Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.